Judith J. Prochaska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Judith J. Prochaska has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Sharon M. Hall
University of California, San Francisco, Department of Psychiatry, United States
7 shared publicationsStephen E. Hall
3 shared publications- Danielle E. Ramo
Hopelab, San Francisco, CA, United States
2 shared publications Desiree Leek
University of California, San Francisco
2 shared publications- Dikla Shmueli-Blumberg
The Emmes Company, LLC
2 shared publications Karen Suchanek Hudmon
Purdue University College of Pharmacy Science, West Lafayette, Indiana
2 shared publications
Latest Publications
- Open Access
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
Objective To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Design Meta-analysis comparing study effects using four summary estimates. Data sources Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Review methods We included randomised controlled trials of current tobacco users of adult age comparing use of varenicline with an inactive control and reporting adverse events. We defined treatment emergent, cardiovascular serious adverse events as occurring during drug treatment or within 30 days of discontinuation, and included any ischaemic or arrhythmic adverse cardiovascular event (myocardial infarction, unstable angina, coronary revascularisation, coronary artery disease, arrhythmias, transient ischaemic attacks, stroke, sudden death or cardiovascular related death, or congestive heart failure). Results We identified 22 trials; all were double blinded and placebo controlled; two included participants with active cardiovascular disease and 11 enrolled participants with a history of cardiovascular disease. Rates of treatment emergent, cardiovascular serious adverse events were 0.63% (34/5431) in the varenicline groups and 0.47% (18/3801) in the placebo groups. The summary estimate for the risk difference, 0.27% (95% confidence interval −0.10 to 0.63; P=0.15), based on all 22 trials, was neither clinically nor statistically significant. For comparison, the relative risk (1.40, 0.82 to 2.39; P=0.22), Mantel-Haenszel odds ratio (1.41, 0.82 to 2.42; P=0.22), and Peto odds ratio (1.58, 0.90 to 2.76; P=0.11), all based on 14 trials with at least one event, also indicated a non-significant difference between varenicline and placebo groups. Conclusions This meta-analysis—which included all trials published to date, focused on events occurring during drug exposure, and analysed findings using four summary estimates—found no significant increase in cardiovascular serious adverse events associated with varenicline use. For rare outcomes, summary estimates based on absolute effects are recommended and estimates based on the Peto odds ratio should be avoided.
Open AccessRisk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
Objective To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Design Meta-analysis comparing study effects using four summary estimates. Data sources Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Review methods We included randomised controlled trials of current tobacco users of adult age comparing use of varenicline with an inactive control and reporting adverse events. We defined treatment emergent, cardiovascular serious adverse events as occurring during drug treatment or within 30 days of discontinuation, and included any ischaemic or arrhythmic adverse cardiovascular event (myocardial infarction, unstable angina, coronary revascularisation, coronary artery disease, arrhythmias, transient ischaemic attacks, stroke, sudden death or cardiovascular related death, or congestive heart failure). Results We identified 22 trials; all were double blinded and placebo controlled; two included participants with active cardiovascular disease and 11 enrolled participants with a history of cardiovascular disease. Rates of treatment emergent, cardiovascular serious adverse events were 0.63% (34/5431) in the varenicline groups and 0.47% (18/3801) in the placebo groups. The summary estimate for the risk difference, 0.27% (95% confidence interval −0.10 to 0.63; P=0.15), based on all 22 trials, was neither clinically nor statistically significant. For comparison, the relative risk (1.40, 0.82 to 2.39; P=0.22), Mantel-Haenszel odds ratio (1.41, 0.82 to 2.42; P=0.22), and Peto odds ratio (1.58, 0.90 to 2.76; P=0.11), all based on 14 trials with at least one event, also indicated a non-significant difference between varenicline and placebo groups. Conclusions This meta-analysis—which included all trials published to date, focused on events occurring during drug exposure, and analysed findings using four summary estimates—found no significant increase in cardiovascular serious adverse events associated with varenicline use. For rare outcomes, summary estimates based on absolute effects are recommended and estimates based on the Peto odds ratio should be avoided.
- 2 May 2012
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 125 (1-2) , 127-131
Correlates of tobacco dependence and motivation to quit among young people receiving mental health treatment
- 2 May 2012
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 125 (1-2) , 127-131
Correlates of tobacco dependence and motivation to quit among young people receiving mental health treatment
- Open Access
- 19 April 2012
- Published by Springer Nature in Addiction Science & Clinical Practice
- Vol. 7 (1) , 1-7
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey
There is elevated prevalence of marijuana use among young adults who use tobacco, but little is known about the extent of co-use generated from surveys conducted online. The purpose of the present study was to examine past-month marijuana use and the co-use of marijuana and tobacco in a convenience sample of young adult smokers with national US coverage. Young adults age 18 to 25 who had smoked at least one cigarette in the past 30 days were recruited online between 4/1/09 and 12/31/10 to participate in an online survey on tobacco use. We examined past 30 day marijuana use, frequency of marijuana use, and proportion of days co-using tobacco and marijuana by demographic characteristics and daily smoking status. Of 3512 eligible and valid survey responses, 1808 (51.5%) smokers completed the survey. More than half (53%, n = 960) of the sample reported past-month marijuana use and reported a median use of 18 out of the past 30 days (interquartile range [IR] = 4, 30). Co-use of tobacco and marijuana occurred on nearly half (median = 45.5%; IR = 13.1, 90.3) of the days on which either substance was used and was more frequent among Caucasians, respondents living in the Northeast or in rural areas, in nonstudents versus students, and in daily versus nondaily smokers. Residence in a state with legalized medical marijuana was unrelated to co-use or even the prevalence of marijuana use in this sample. Age and household income also were unrelated to co-use of tobacco and marijuana. These results indicate a higher prevalence of marijuana use and co-use of tobacco in young adult smokers than is reported in nationally representative surveys. Cessation treatments for young adult smokers should consider broadening intervention targets to include marijuana.
- 19 April 2012
- Published by Springer Nature in Addiction Science & Clinical Practice
- Vol. 7 (1) , 1-7
Open AccessPrevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey
There is elevated prevalence of marijuana use among young adults who use tobacco, but little is known about the extent of co-use generated from surveys conducted online. The purpose of the present study was to examine past-month marijuana use and the co-use of marijuana and tobacco in a convenience sample of young adult smokers with national US coverage. Young adults age 18 to 25 who had smoked at least one cigarette in the past 30 days were recruited online between 4/1/09 and 12/31/10 to participate in an online survey on tobacco use. We examined past 30 day marijuana use, frequency of marijuana use, and proportion of days co-using tobacco and marijuana by demographic characteristics and daily smoking status. Of 3512 eligible and valid survey responses, 1808 (51.5%) smokers completed the survey. More than half (53%, n = 960) of the sample reported past-month marijuana use and reported a median use of 18 out of the past 30 days (interquartile range [IR] = 4, 30). Co-use of tobacco and marijuana occurred on nearly half (median = 45.5%; IR = 13.1, 90.3) of the days on which either substance was used and was more frequent among Caucasians, respondents living in the Northeast or in rural areas, in nonstudents versus students, and in daily versus nondaily smokers. Residence in a state with legalized medical marijuana was unrelated to co-use or even the prevalence of marijuana use in this sample. Age and household income also were unrelated to co-use of tobacco and marijuana. These results indicate a higher prevalence of marijuana use and co-use of tobacco in young adult smokers than is reported in nationally representative surveys. Cessation treatments for young adult smokers should consider broadening intervention targets to include marijuana.
- Top Cited Papers
- 1 March 2012
- Published by Elsevier in Clinical Psychology Review
- Vol. 32 (2) , 105-121
Tobacco and marijuana use among adolescents and young adults: A systematic review of their co-use
- 1 March 2012
- Published by Elsevier in Clinical Psychology Review
- Vol. 32 (2) , 105-121
Top Cited PapersTobacco and marijuana use among adolescents and young adults: A systematic review of their co-use
- Top Cited PapersOpen Access
- 20 February 2012
- Published by Wiley in International Journal of Methods in Psychiatric Research
- Vol. 21 (2) , 88-97
Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization
The widely‐used Kessler K6 non‐specific distress scale screens for severe mental illness defined as a K6 score ≥ 13, estimated to afflict about 6% of US adults. The K6, as currently used, fails to capture individuals struggling with more moderate mental distress that nonetheless warrants mental health intervention. The current study determined a cutoff criterion on the K6 scale indicative of moderate mental distress based on mental health treatment need and assessed the validity of this criterion by comparing participants with identified moderate and severe mental distress on relevant clinical, impairment, and risk behavior measures. Data were analyzed from 50,880 adult participants in the 2007 California Health Interview Survey. Receiver operating characteristic curve analysis identified K6 ≥ 5 as the optimal lower threshold cut‐point indicative of moderate mental distress. Based on the K6, 8.6% of California adults had serious mental distress and another 27.9% had moderate mental distress. Correlates of moderate and serious mental distress were similar. Respondents with moderate mental distress had rates of mental health care utilization, impairment, substance use and other risks lower than respondents with serious mental distress and greater than respondents with none/low mental distress. The findings support expanded use and analysis of the K6 scale in quantifying and examining correlates of mental distress at a moderate, yet still clinically relevant, level. Copyright © 2012 John Wiley & Sons, Ltd.
- 20 February 2012
- Published by Wiley in International Journal of Methods in Psychiatric Research
- Vol. 21 (2) , 88-97
Top Cited PapersOpen AccessValidity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization
The widely‐used Kessler K6 non‐specific distress scale screens for severe mental illness defined as a K6 score ≥ 13, estimated to afflict about 6% of US adults. The K6, as currently used, fails to capture individuals struggling with more moderate mental distress that nonetheless warrants mental health intervention. The current study determined a cutoff criterion on the K6 scale indicative of moderate mental distress based on mental health treatment need and assessed the validity of this criterion by comparing participants with identified moderate and severe mental distress on relevant clinical, impairment, and risk behavior measures. Data were analyzed from 50,880 adult participants in the 2007 California Health Interview Survey. Receiver operating characteristic curve analysis identified K6 ≥ 5 as the optimal lower threshold cut‐point indicative of moderate mental distress. Based on the K6, 8.6% of California adults had serious mental distress and another 27.9% had moderate mental distress. Correlates of moderate and serious mental distress were similar. Respondents with moderate mental distress had rates of mental health care utilization, impairment, substance use and other risks lower than respondents with serious mental distress and greater than respondents with none/low mental distress. The findings support expanded use and analysis of the K6 scale in quantifying and examining correlates of mental distress at a moderate, yet still clinically relevant, level. Copyright © 2012 John Wiley & Sons, Ltd.
- 4 January 2012
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 27 (6) , 700-707
Medical Students’ Attention to Multiple Risk Behaviors: A Standardized Patient Examination
Risk behaviors tend to cluster, particularly among smokers, with negative health effects. To optimize patients’ health and wellbeing, health care providers ideally would assess and intervene upon the multiple risks with which patients may present. This study examined medical students’ skills in assessing and treating multiple risk behaviors. Using a randomized experimental design, medical students’ counseling interactions were evaluated with a standardized patient presenting with sexual health concerns and current tobacco use with varied problematic drinking status (alcohol-positive or alcohol-negative). One hundred and fifty-six third-year medical students. Student and standardized patient completed measures evaluated student knowledge, attitudes, and clinical performance. Overall, most students assessed tobacco use (85%); fewer assessed alcohol use (54%). Relative to the alcohol-negative case, students seeing the alcohol-positive case were less likely to assess sexually transmitted disease history (80% vs. 91%, p = 0.042), or patients’ readiness to quit smoking (41% vs. 60%, p = 0.025), and endorsed greater attitudinal barriers to tobacco treatment (p = 0.030). Patient satisfaction was significantly lower for the alcohol-positive than the alcohol-negative case; clinical performance ratings moderated this relationship. When presented with a case of multiple risks, medical students performed less effectively and received lower patient satisfaction ratings. Findings were moderated by students’ overall clinical performance. Paradigm shifts are needed in medical education that emphasize assessment of multiple risks, new models of conceptualizing behavior change as a generalized process, and treatment of the whole patient for optimizing health outcomes.
- 4 January 2012
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 27 (6) , 700-707
Medical Students’ Attention to Multiple Risk Behaviors: A Standardized Patient Examination
Risk behaviors tend to cluster, particularly among smokers, with negative health effects. To optimize patients’ health and wellbeing, health care providers ideally would assess and intervene upon the multiple risks with which patients may present. This study examined medical students’ skills in assessing and treating multiple risk behaviors. Using a randomized experimental design, medical students’ counseling interactions were evaluated with a standardized patient presenting with sexual health concerns and current tobacco use with varied problematic drinking status (alcohol-positive or alcohol-negative). One hundred and fifty-six third-year medical students. Student and standardized patient completed measures evaluated student knowledge, attitudes, and clinical performance. Overall, most students assessed tobacco use (85%); fewer assessed alcohol use (54%). Relative to the alcohol-negative case, students seeing the alcohol-positive case were less likely to assess sexually transmitted disease history (80% vs. 91%, p = 0.042), or patients’ readiness to quit smoking (41% vs. 60%, p = 0.025), and endorsed greater attitudinal barriers to tobacco treatment (p = 0.030). Patient satisfaction was significantly lower for the alcohol-positive than the alcohol-negative case; clinical performance ratings moderated this relationship. When presented with a case of multiple risks, medical students performed less effectively and received lower patient satisfaction ratings. Findings were moderated by students’ overall clinical performance. Paradigm shifts are needed in medical education that emphasize assessment of multiple risks, new models of conceptualizing behavior change as a generalized process, and treatment of the whole patient for optimizing health outcomes.
- 1 January 2012
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 26 (1) , 157-161
A test of positive affect induction for countering self-control depletion in cigarette smokers.
The self-control strength model posits that exerting self-control on one task, such as resisting temptations, will deplete self-control and impair subsequent self-regulatory performance, such as controlling smoking. The current study examined interventions designed to replenish depleted self-control strength to prevent tobacco use by inducing positive affect. In a 2 × 2 design, 200 participants were randomized to either (1) resist eating from a plate of desserts (high temptation) or from a plate of raw vegetables (low temptation) and then (2) undergo a positive or neutral affect induction. Two inductions were compared (video vs. writing technique). Participants were then given a 10-min recess. Whether or not participants smoked during the recess, assessed by self-report and biochemical verification, served as the primary dependent variable. The interaction between depletion and exposure group was significant, Wald's χ² = 9.66, df = 3, p < .05. Among those assigned to resist desserts, 65.5% to 85% smoked if they were in the neutral video or writing conditions versus 10.5% in the positive affect video group. Positive affect elicited with a video was able to counteract the detrimental effects of self-control depletion on smoking behavior, while writing exercises were associated with smoking. Implications for tobacco cessation intervention are discussed.
- 1 January 2012
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 26 (1) , 157-161
A test of positive affect induction for countering self-control depletion in cigarette smokers.
The self-control strength model posits that exerting self-control on one task, such as resisting temptations, will deplete self-control and impair subsequent self-regulatory performance, such as controlling smoking. The current study examined interventions designed to replenish depleted self-control strength to prevent tobacco use by inducing positive affect. In a 2 × 2 design, 200 participants were randomized to either (1) resist eating from a plate of desserts (high temptation) or from a plate of raw vegetables (low temptation) and then (2) undergo a positive or neutral affect induction. Two inductions were compared (video vs. writing technique). Participants were then given a 10-min recess. Whether or not participants smoked during the recess, assessed by self-report and biochemical verification, served as the primary dependent variable. The interaction between depletion and exposure group was significant, Wald's χ² = 9.66, df = 3, p < .05. Among those assigned to resist desserts, 65.5% to 85% smoked if they were in the neutral video or writing conditions versus 10.5% in the positive affect video group. Positive affect elicited with a video was able to counteract the detrimental effects of self-control depletion on smoking behavior, while writing exercises were associated with smoking. Implications for tobacco cessation intervention are discussed.
- Open Access
- 10 October 2011
- Published by Wiley in Clinical Cardiology
- Vol. 34 (12) , 738-743
Cardiology Rx for Change: Improving Clinical Attention to Tobacco Use and Secondhand Smoke Exposure in Cardiology
Background: Heart disease is the leading cause of tobacco‐related death in smokers and of deaths due to secondhand smoke (SHS) exposure in nonsmokers. This study centers on the development and evaluation of an evidence‐based model curriculum for improving clinical attention to tobacco use and SHS exposure in cardiology. Hypothesis: We hypothesized that the curriculum would be associated with improvements in clinician tobacco‐related knowledge, attitudes, confidence, and counseling behaviors from pre‐to post‐training and at the 3‐month follow‐up. Methods: The 1‐hour Cardiology Rx for Change curriculum was evaluated with 22 cardiology fellows and 77 medical residents with consistent training effects observed between the 2 groups. Results: Trainees' tobacco treatment knowledge increased significantly from pre‐ to post‐training (t[81] = 6.51, P<0.001), and perceived barriers to providing cessation treatment decreased significantly (t[81] = −3.97, P<0.001). The changes, however, were not sustained at the 3‐month follow‐up, suggesting the need for booster training efforts. From pretraining to 3‐month follow‐up, the training was associated with significant sustained gains in clinician confidence for treating tobacco dependence (t[61] = 3.69, P = 0.001) and with improvements in clinicians assessing patients' readiness to quit smoking (from 61% to 79%, t[59] = 3.69,P<0.001) and providing assistance with quitting (from 47% to 59%, t[59] = 2.12, P = 0.038). Asking patients about tobacco use, advising cessation, and arranging follow‐up also increased over time, but not significantly. All participants (100%) recommended the curriculum for dissemination to other training programs. Conclusions: Available online via http://rxforchange.ucsf.edu, Cardiology Rx for Change offers a packaged training tool for improving treatment of tobacco use and SHS exposure in cardiology care. © 2011 Wiley Periodicals, Inc. This work was supported by the Flight Attendant Medical Research Institute (FAMRI) William Cahan Distinguished Professor Award (PI: W. Grossman), and the State of California Tobacco‐Related Disease Research Program (# 17RT‐0077, PI: J.J. Prochaska). The authors have no other funding, financial relationships, or conflicts of interest to disclose.
- 10 October 2011
- Published by Wiley in Clinical Cardiology
- Vol. 34 (12) , 738-743
Open AccessCardiology Rx for Change: Improving Clinical Attention to Tobacco Use and Secondhand Smoke Exposure in Cardiology
Background: Heart disease is the leading cause of tobacco‐related death in smokers and of deaths due to secondhand smoke (SHS) exposure in nonsmokers. This study centers on the development and evaluation of an evidence‐based model curriculum for improving clinical attention to tobacco use and SHS exposure in cardiology. Hypothesis: We hypothesized that the curriculum would be associated with improvements in clinician tobacco‐related knowledge, attitudes, confidence, and counseling behaviors from pre‐to post‐training and at the 3‐month follow‐up. Methods: The 1‐hour Cardiology Rx for Change curriculum was evaluated with 22 cardiology fellows and 77 medical residents with consistent training effects observed between the 2 groups. Results: Trainees' tobacco treatment knowledge increased significantly from pre‐ to post‐training (t[81] = 6.51, P<0.001), and perceived barriers to providing cessation treatment decreased significantly (t[81] = −3.97, P<0.001). The changes, however, were not sustained at the 3‐month follow‐up, suggesting the need for booster training efforts. From pretraining to 3‐month follow‐up, the training was associated with significant sustained gains in clinician confidence for treating tobacco dependence (t[61] = 3.69, P = 0.001) and with improvements in clinicians assessing patients' readiness to quit smoking (from 61% to 79%, t[59] = 3.69,P<0.001) and providing assistance with quitting (from 47% to 59%, t[59] = 2.12, P = 0.038). Asking patients about tobacco use, advising cessation, and arranging follow‐up also increased over time, but not significantly. All participants (100%) recommended the curriculum for dissemination to other training programs. Conclusions: Available online via http://rxforchange.ucsf.edu, Cardiology Rx for Change offers a packaged training tool for improving treatment of tobacco use and SHS exposure in cardiology care. © 2011 Wiley Periodicals, Inc. This work was supported by the Flight Attendant Medical Research Institute (FAMRI) William Cahan Distinguished Professor Award (PI: W. Grossman), and the State of California Tobacco‐Related Disease Research Program (# 17RT‐0077, PI: J.J. Prochaska). The authors have no other funding, financial relationships, or conflicts of interest to disclose.
- 1 August 2011
- Published by Wiley in Bipolar Disorders
- Vol. 13 (5-6) , 466-473
An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder
Prochaska JJ, Reyes RS, Schroeder SA, Daniels AS, Doederlein A, Bergeson B. An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disord 2011: 13: 466–473. © 2011 The Authors. Journal compilation © 2011 John Wiley & Sons A/S.Objectives: Tobacco use is prevalent among people living with bipolar disorder. We examined tobacco use, attempts to quit, and tobacco‐related attitudes and intentions among 685 individuals with bipolar disorder who smoked ≥ 100 cigarettes in their lifetime.Methods: Data were collected online through the website of the Depression and Bipolar Support Alliance, a mood disorder peer‐support network.Results: The sample was 67% female, 67% aged 26 to 50, and 89% Caucasian; 87% were current smokers; 92% of current smokers smoked daily, averaging 19 cigarettes/day (SD = 11). The sample began smoking at a mean age of 17 years (SD = 6) and smoked a median of 7 years prior to bipolar disorder diagnosis. Among current smokers, 74% expressed a desire to quit; intent to quit smoking was unrelated to current mental health symptoms [χ2(3) = 5.50, p = 0.139]. Only 33% were advised to quit smoking by a mental health provider, 48% reported smoking to treat their mental illness, and 96% believed being mentally healthy was important for quitting. Ex‐smokers (13% of sample) had not smoked for a median of 2.7 years; 48% quit ‘cold turkey.’ Most ex‐smokers (64%) were in poor or fair mental health when they quit smoking. At the time of the survey, however, more ex‐smokers described their mental health as in recovery than current smokers [57% versus 40%; χ2(3) = 11.12, p = 0.011].Conclusions: Most smokers living with bipolar disorder are interested in quitting. The Internet may be a useful cessation tool for recruiting and potentially treating smokers with bipolar disorder who face special challenges when trying to quit and rarely receive cessation treatment from their mental health providers.
- 1 August 2011
- Published by Wiley in Bipolar Disorders
- Vol. 13 (5-6) , 466-473
An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder
Prochaska JJ, Reyes RS, Schroeder SA, Daniels AS, Doederlein A, Bergeson B. An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disord 2011: 13: 466–473. © 2011 The Authors. Journal compilation © 2011 John Wiley & Sons A/S.Objectives: Tobacco use is prevalent among people living with bipolar disorder. We examined tobacco use, attempts to quit, and tobacco‐related attitudes and intentions among 685 individuals with bipolar disorder who smoked ≥ 100 cigarettes in their lifetime.Methods: Data were collected online through the website of the Depression and Bipolar Support Alliance, a mood disorder peer‐support network.Results: The sample was 67% female, 67% aged 26 to 50, and 89% Caucasian; 87% were current smokers; 92% of current smokers smoked daily, averaging 19 cigarettes/day (SD = 11). The sample began smoking at a mean age of 17 years (SD = 6) and smoked a median of 7 years prior to bipolar disorder diagnosis. Among current smokers, 74% expressed a desire to quit; intent to quit smoking was unrelated to current mental health symptoms [χ2(3) = 5.50, p = 0.139]. Only 33% were advised to quit smoking by a mental health provider, 48% reported smoking to treat their mental illness, and 96% believed being mentally healthy was important for quitting. Ex‐smokers (13% of sample) had not smoked for a median of 2.7 years; 48% quit ‘cold turkey.’ Most ex‐smokers (64%) were in poor or fair mental health when they quit smoking. At the time of the survey, however, more ex‐smokers described their mental health as in recovery than current smokers [57% versus 40%; χ2(3) = 11.12, p = 0.011].Conclusions: Most smokers living with bipolar disorder are interested in quitting. The Internet may be a useful cessation tool for recruiting and potentially treating smokers with bipolar disorder who face special challenges when trying to quit and rarely receive cessation treatment from their mental health providers.
- 5 July 2011
- Published by BMJ in Tobacco Control
- Vol. 21 (4) , 447-449
Twitter=quitter? An analysis of Twitter quit smoking social networks
Objective Widely popular, Twitter, a free social networking and micro-blogging service, offers potential for health promotion. This study examined the activity of Twitter quit smoking social network accounts. Design A cross‐sectional analysis identified 153 activated Twitter quit smoking accounts dating back to 2007 and examined recent account activity for the month of August 2010. Results The accounts had a median of 155 followers and 82 total tweets per account; 49% of accounts had >100 tweets. Posted content was largely inconsistent with clinical guidelines; 48% linked to commercial sites for quitting smoking and 43% had tweets on e‐cigarettes. In August 2010, 81 of the accounts (53%) were still active. Conclusions Though popular for building quit smoking social networks, many of the Twitter accounts were no longer active, and tweet content was largely inconsistent with clinical guidelines. Future research is needed to examine the effectiveness of Twitter for supporting smoking cessation.
- 5 July 2011
- Published by BMJ in Tobacco Control
- Vol. 21 (4) , 447-449
Twitter=quitter? An analysis of Twitter quit smoking social networks
Objective Widely popular, Twitter, a free social networking and micro-blogging service, offers potential for health promotion. This study examined the activity of Twitter quit smoking social network accounts. Design A cross‐sectional analysis identified 153 activated Twitter quit smoking accounts dating back to 2007 and examined recent account activity for the month of August 2010. Results The accounts had a median of 155 followers and 82 total tweets per account; 49% of accounts had >100 tweets. Posted content was largely inconsistent with clinical guidelines; 48% linked to commercial sites for quitting smoking and 43% had tweets on e‐cigarettes. In August 2010, 81 of the accounts (53%) were still active. Conclusions Though popular for building quit smoking social networks, many of the Twitter accounts were no longer active, and tweet content was largely inconsistent with clinical guidelines. Future research is needed to examine the effectiveness of Twitter for supporting smoking cessation.